Literature DB >> 23424098

The effect of continuous infusion loop diuretics in patients with acute decompensated heart failure with hypoalbuminemia.

Barry E Bleske1, Megan M Clark, Audrey H Wu, Michael P Dorsch.   

Abstract

PURPOSE: Hypoalbuminemia is believed to decrease diuretic effectiveness and contribute to diuretic resistance that is observed in patients with nephrotic syndrome. Hypoalbuminemia is also seen in patients with acute decompensated heart failure (ADHF). However, the role of hypoalbuminemia on the effectiveness of continuous infusion diuretics in patients with ADHF is not known.
METHODS: To evaluate hypoalbuminemia (albumin ≤ 3 g/dL) and diuretic effectiveness, we performed a retrospective study in 162 patients admitted to a tertiary care center for treatment of ADHF over a 3-year period. All patients received continuous infusion diuretic for at least a 2-day time period.
RESULTS: A total of 33 patients were determined to have hypoalbuminemia. Average net urine output over a 2-day study period was similar between patients with and without hypoalbuminemia (-1462 ± 1734 vs -1233 ± 1560 mL, P = .46, respectively). In addition, diuretic doses (furosemide equivalent/24 hours) were similar between the 2 groups (788 ± 671 vs 778 ± 713 mg, P = .91, respectively) as was baseline serum creatinine (1.6 ± 0.6 vs 1.6 ± 0.6 mg/dL, P = .5, respectively).
CONCLUSION: Overall, hypoalbuminemia did not decrease the diuretic effectiveness when measured by the net urine output in patients receiving continuous infusion diuretics for the treatment of ADHF.

Entities:  

Keywords:  continuous infusion; diuretics; heart failure; hypoalbuminemia

Mesh:

Substances:

Year:  2013        PMID: 23424098     DOI: 10.1177/1074248412474347

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  6 in total

1.  Serum and Urine Albumin and Response to Loop Diuretics in Heart Failure.

Authors:  Antonios Charokopos; Matthew Griffin; Veena S Rao; Lesley Inker; Krishna Sury; Jennifer Asher; Jeffrey Turner; Devin Mahoney; Zachary L Cox; F Perry Wilson; Jeffrey M Testani
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-22       Impact factor: 8.237

2.  Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF).

Authors:  Justin L Grodin; Dianne Gallup; Kevin J Anstrom; G Michael Felker; Horng H Chen; W H Wilson Tang
Journal:  Am J Cardiol       Date:  2017-03-29       Impact factor: 2.778

3.  Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHF.

Authors:  Justin L Grodin; Anuradha Lala; Susanna R Stevens; Adam D DeVore; Lauren B Cooper; Omar F AbouEzzeddine; Robert J Mentz; John D Groarke; Emer Joyce; Julie L Rosenthal; Justin M Vader; W H Wilson Tang
Journal:  J Card Fail       Date:  2016-02-02       Impact factor: 5.712

4.  Evaluation of the efficacy & biochemical mechanism of cell death induction by Piper longum extract selectively in in-vitro and in-vivo models of human cancer cells.

Authors:  Pamela Ovadje; Dennis Ma; Phillip Tremblay; Alessia Roma; Matthew Steckle; Jose-Antonio Guerrero; John Thor Arnason; Siyaram Pandey
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

5.  Effects of tolvaptan on urine output in hospitalized heart failure patients with hypoalbuminemia or proteinuria.

Authors:  Koji Takagi; Naoki Sato; Shiro Ishihara; Michiko Sone; Hideo Tokuyama; Kenji Nakama; Toshiya Omote; Arifumi Kikuchi; Masahiro Ishikawa; Kenichi Amitani; Naoto Takahashi; Yuji Maruyama; Hajime Imura; Wataru Shimizu
Journal:  Heart Vessels       Date:  2017-10-23       Impact factor: 2.037

6.  Association of admission vs. nadir serum albumin concentration with short-term treatment outcomes in patients with acute heart failure.

Authors:  Evan J Peterson; Tien M H Ng; Komal A Patel; Mimi Lou; Uri Elkayam
Journal:  J Int Med Res       Date:  2018-06-04       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.